We are live on ! Find out more
CRMD icon

CorMedix

101 hedge funds and large institutions have $71.4M invested in CorMedix in 2023 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 37 increasing their positions, 20 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

113% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 8

85% more repeat investments, than reductions

Existing positions increased: 37 | Existing positions reduced: 20

10% more funds holding

Funds holding: 92101 (+9)

8% more capital invested

Capital invested by funds: $66.2M → $71.4M (+$5.21M)

2.01% more ownership

Funds ownership: 32.64%34.65% (+2%)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

63% less call options, than puts

Call options by funds: $551K | Put options by funds: $1.51M

Holders
101
Holders Change
+9
Holders Change %
+9.78%
% of All Funds
1.47%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
17
Increased
37
Reduced
20
Closed
8
Calls
$551K
Puts
$1.51M
Net Calls
-$955K
Net Calls Change
+$292K
Name Holding Trade Value Shares
Change
Change in
Stake
Deutsche Bank
51
Deutsche Bank
Germany
$108K
SG Americas Securities
52
SG Americas Securities
New York
$107K +$98K +28,465 New
VF
53
Virtu Financial
New York
$103K +$94.2K +27,379 New
AIG
54
American International Group
New York
$103K +$4.46K +1,297 +5%
MA
55
MJP Associates
Connecticut
$94K +$86K +25,000 New
GCP
56
GSA Capital Partners
United Kingdom
$93K +$85.1K +24,721 New
BPA
57
Beacon Pointe Advisors
California
$90.2K +$82.6K +24,000 New
Mirae Asset Global Investments
58
Mirae Asset Global Investments
South Korea
$89.3K
MIM
59
MetLife Investment Management
New Jersey
$89.1K
VOYA Investment Management
60
VOYA Investment Management
Georgia
$86.8K +$3.64K +1,059 +5%
TSS
61
Two Sigma Securities
New York
$83.6K +$76.5K +22,244 New
LPL Financial
62
LPL Financial
California
$82K +$3.44K +1,000 +5%
Dimensional Fund Advisors
63
Dimensional Fund Advisors
Texas
$81.2K
Royal Bank of Canada
64
Royal Bank of Canada
Ontario, Canada
$76K +$39.5K +11,490 +132%
Manulife (Manufacturers Life Insurance)
65
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$75.7K
HighTower Advisors
66
HighTower Advisors
Illinois
$73K
WEG
67
World Equity Group
Illinois
$69.2K
New York State Common Retirement Fund
68
New York State Common Retirement Fund
New York
$67.8K -$410 -119 -0.7%
CSS
69
Cubist Systematic Strategies
Connecticut
$64.9K +$15.5K +4,490 +35%
Wolverine Trading
70
Wolverine Trading
Illinois
$60.5K +$55.4K +16,101 New
Wells Fargo
71
Wells Fargo
California
$59.3K +$13.6K +3,963 +34%
State Board of Administration of Florida Retirement System
72
State Board of Administration of Florida Retirement System
Florida
$55.9K
TRCT
73
Tower Research Capital (TRC)
New York
$52.6K +$36.8K +10,695 +325%
AllianceBernstein
74
AllianceBernstein
Tennessee
$50.8K
T. Rowe Price Associates
75
T. Rowe Price Associates
Maryland
$46K

CRMD Hedge Fund Activity: Q4 2023 in Review

101 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in CorMedix (CRMD) for Q4 2023, worth a combined $71.4M — up 7.9% from $66.2M a quarter earlier.

Buyers outnumbered sellers: 17 funds opened new CRMD positions and 8 closed out — a net gain of 9 holders — while 37 added to existing stakes and 20 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $1.27M. The largest seller was Marshall Wace, cutting an estimated $1.55M.

  • 101 institutional investors held CorMedix (CRMD) as of Q4 2023, up from 92 in Q3 2023.
  • Funds reported $71.4M of CorMedix stock for Q4 2023, up 7.9% quarter-over-quarter.
  • 17 funds opened new CorMedix positions in Q4 2023 and 8 closed out, a net change of +9 holders.
  • The largest CorMedix buyer in Q4 2023 was Morgan Stanley, an estimated $1.27M added.
  • The largest CorMedix seller in Q4 2023 was Marshall Wace, an estimated $1.55M sold.

Based on aggregated 13F filings for Q4 2023.